Skip to main content

Published locations for Bezlotoxumab beats placebo at preventing recurrent C. difficile infections in high-risk patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Bezlotoxumab beats placebo at preventing recurrent C. difficile infections in high-risk patients

User login

  • Reset your password
  • /content/bezlotoxumab-beats-placebo-preventing-recurrent-c-difficile-infections-high-risk-patients
  • /familypracticenews/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing
  • /gihepnews/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing-recurrent-c
  • /idpractitioner/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing-recurrent-c
  • /internalmedicinenews/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing
  • /infectiousdisease/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing-recurrent
  • /internalmedicine/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing-recurrent
  • /familymedicine/article/109447/infectious-diseases/bezlotoxumab-beats-placebo-preventing-recurrent-c